SHANGHAI & BOSTON–(Business WIRE)–Mar 1, 2022–
Overland Pharmaceuticals (“Overland”), a leading biopharmaceutical organization bringing modern medications to sufferers in Asia and worldwide, nowadays declared the appointment of Xun Liu, Ph.D., as Chief Technological innovation Officer (CTO). In this new part, Dr. Liu will be dependable for overseeing the company’s worldwide technological operations including chemistry, manufacturing, and controls (CMC) of merchandise development and commercialization.
This press release attributes multimedia. Look at the whole release below: https://www.businesswire.com/information/household/20220301005224/en/
Xun Liu, Ph.D. (Photo: Enterprise Wire)
“Dr. Liu’s abilities in the biopharmaceutical field and verified keep track of file of accomplishment make him the ideal addition to our group to enable guide the advancement of our ground breaking therapeutic candidates,” stated Ed Zhang, MBA, Co-founder and Main Govt Officer of Overland. “Dr. Liu brings almost 30 decades of world-wide biopharmaceutical industry knowledge covering numerous stages of the product lifestyle cycle, from pre-clinical investigation and enhancement to product industrial producing. His deep CMC and drug improvement capabilities align with Overland’s scientific, regulatory, and commercialization options and will tell the evolution of our flexible partnering design concentrating on innovative modalities these as mobile and gene treatment, antibody drug conjugates, mRNA, and far more. We search forward to Dr. Liu signing up for our workforce and leveraging his expertise and encounter to support velocity up our merchandise advancement and commercialization.”
Dr. Liu added, “I am thrilled to be a component of Overland’s staff and I search ahead to doing work with our R&D colleagues to help create new therapeutic modalities, offering complex assist to the business growth group in the look for and institution of new enterprise alliances, and collaborating with our existing partners to aid commercialization of merchandise in the pipeline.”
Dr. Liu will carry on serving in his position as Senior Advisor at Hillhouse Expenditure, a situation he has held to date. Prior to joining Hillhouse Investment, Dr. Liu was the Vice President of Hengrui Medicine and the President of its Biomedicine Improvement and Company Division wherever he oversaw the improvement of in excess of 50 new biological products, 23 of which entered scientific trials and 3 ended up authorised for current market start. Previously, Dr. Liu was a tenured Staff Scientist at the Vaccine Investigation Heart of the National Institutes of Health and fitness (NIH), where by he was in demand of method improvement and medical production of therapeutic and prophylactic vaccines. Prior to his function at the NIH, he was the Principal Engineer at Bayer Healthcare Pharmaceuticals, serving as Industrial Creation Professional for Kogenate®, Bayer’s top marketing drug. Before in his occupation, he worked at Amgen and Vertex Prescribed drugs in many drug enhancement roles. Dr. Liu acquired a Bachelor of Science diploma in chemistry from Beijing University and Ph.D. diploma in biophysical chemistry from Rutgers College. Following his training, he was skilled at Massachusetts Institute of Technology (MIT) as a article-doc fellow in the Nobel Laureate Professor Gobind Khorana’s laboratory for 3 and a fifty percent yrs.
About Overland Prescribed drugs
Overland Prescribed drugs is setting up a fully integrated biopharma organization with a mission to deliver progressive medicines to underserved patients in Asia and close to the environment. By leveraging our sources, world wide community, and local abilities throughout the biopharma ecosystem in Asia, Overland is establishing a portfolio of differentiated therapeutic candidates in a number of meticulously chosen therapeutic places. By way of formative partnerships, Overland will push the advancement and commercialization of the most promising advancements in drugs. www.overlandpharma.com
Look at source edition on businesswire.com:https://www.businesswire.com/information/dwelling/20220301005224/en/
Kari Watson or Madeline Davidshofer
Search phrase: CHINA UNITED STATES NORTH The usa ASIA PACIFIC MASSACHUSETTS
Industry Key word: BIOTECHNOLOGY Wellbeing SCIENCE PHARMACEUTICAL Exploration
Resource: Overland Pharmaceuticals
Copyright Business enterprise Wire 2022.
PUB: 03/01/2022 07:00 AM/DISC: 03/01/2022 07:02 AM
Copyright Organization Wire 2022.